Metoclopramide and unintended weight gain
β Scribed by Sansone, Randy A. ;Sansone, Lori A.
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2003
- Tongue
- English
- Weight
- 50 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0276-3478
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Objective
This paper describes the case of a 19βyearβold female with anorexia nervosa (restricting type) who was prescribed metoclopramide (Reglan, Robins, Richmond, VA) for delayed gastric emptying. She subsequently experienced dramatic and unintended weight gain.
Results
The initial treatment of delayed gastric emptying with metoclopramide did not result in a significant change in body weight. However, an increase in the dose resulted in a 20% increase in the patient's body weight over a 2βmonth period.
Discussion
The risks of weight gain that accompany the administration of metoclopramide are discussed, as well as the postulated etiology and psychological implications for the patient. Β© 2003 by Wiley Periodicals, Inc. Int J Eat Disord 34: 265β268, 2003.
π SIMILAR VOLUMES
This study examined patients with schizophrenic disorders treated with clozapine in a state hospital setting. Gender and diet affected weight gain over a six-month period. Pre-treatment weight status also related to eventual weight gain. There were no significant effects of dosage. Weight gain was m
Excessive deposition of central body and abdominal (centripetal) fat early in life often will presage the later development of cardiovascular and metabolic diseases. Data from urban, low-income women from Camden, New Jersey, were used to examine the influence of gestational weight gain on patterns o